ID   PG/B95-8
AC   CVCL_Y555
SY   PG-B95-8; PG-EBV
DR   Cell_Model_Passport; SIDM01849
DR   DSMZ; ACC-776
DR   DSMZCellDive; ACC-776
DR   Wikidata; Q54947312
RX   PubMed=2836321;
RX   PubMed=23297799;
CC   Population: Caucasian.
CC   Doubling time: ~35 hours (DSMZ=ACC-776).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-776
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 8,12
ST   D16S539: 9,12
ST   D18S51: 15
ST   D19S433: 14,15
ST   D21S11: 28,30
ST   D2S1338: 18
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 20,22
ST   Penta D: 9,13
ST   Penta E: 7,12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y545 ! PGA-1
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 02-05-24; Version: 13
//
RX   PubMed=2836321; DOI=10.1002/ijc.2910410621;
RA   Lewin N., Aman P., Mellstedt H., Zech L., Klein G.;
RT   "Direct outgrowth of in vivo Epstein-Barr virus (EBV)-infected chronic
RT   lymphocytic leukemia (CLL) cells into permanent lines.";
RL   Int. J. Cancer 41:892-895(1988).
//
RX   PubMed=23297799; DOI=10.3109/10428194.2013.764418;
RA   Myhrinder A.L., Hellqvist E., Bergh A.-C., Jansson M.,
RA   Nilsson K., Hultman P., Jonasson J., Buhl A.M., Pedersen L.B.,
RA   Jurlander J., Klein E., Weit N., Herling M., Rosenquist R., Rosen A.;
RT   "Molecular characterization of neoplastic and normal 'sister'
RT   lymphoblastoid B-cell lines from chronic lymphocytic leukemia.";
RL   Leuk. Lymphoma 54:1769-1779(2013).
//